Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

2.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

3.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

4.

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

5.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot